National Early Inflammatory Arthritis Audit (NEIAA)

National Clinical Audit

British Society of Rheumatology
Delivered by:
British Society for Rheumatology (BSR)
Website:
NEIAA

This programme aims to improve the quality of care for people living with inflammatory arthritis, collecting information on all new patients over the age of 16 in specialist rheumatology departments in England, Wales and Jersey. It also collects data at diagnosis for some rare immune mediated inflammatory diseases (IMIDs).

Delays in treatment can lead to disability, reduced quality of life and loss of productivity in the workforce.” NEIAA State of the Nation Summary report 2025

Data is collected for patients with a diagnosis of Early Inflammatory Arthritis (EIA), to assess performance relating to key measures such as waiting times, time to treatment, clinical response to treatment, and patient-reported outcomes.

Supporting improvement

NEIAA generates service-level data across England, Wales and Jersey, benchmarked to regional and national comparators against NICE Quality Standard 33 and other key metrics.

Additional data and resources

In addition to the HQIP-commissioned reports below, further data and resources can be found on the programme website.

Latest reports

See all reports from this programme >

Impact reports

The National Early Inflammatory Arthritis Audit (NEIAA)
May 2025
Download report